Wondering how to use Matinas in a sentence? Below are 2 example sentences from authentic English texts. .
Context around Matinas
- Average sentence length in these examples: 26.5 words
- Position in the sentence: 1 start, 0 middle, 1 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Matinas
- In this selection, "matinas" usually appears near the start of the sentence. The average example has 26.5 words, and this corpus slice is mostly made up of statements.
- Around the word, reached and biopharma stand out and add context to how "matinas" is used.
- Recognizable usage signals include coverage for matinas biopharma and matinas reached alignment. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "matinas" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with matinas
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that that provide coverage for Matinas Biopharma. (24 words)
Matinas reached alignment with the FDA on the design of a single Phase 3 registration trial of oral MAT2203 in patients with invasive aspergillosis who have limited treatment options. (29 words)
Matinas reached alignment with the FDA on the design of a single Phase 3 registration trial of oral MAT2203 in patients with invasive aspergillosis who have limited treatment options. (29 words)
Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that that provide coverage for Matinas Biopharma. (24 words)
Example sentences (2)
Matinas reached alignment with the FDA on the design of a single Phase 3 registration trial of oral MAT2203 in patients with invasive aspergillosis who have limited treatment options.
Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that that provide coverage for Matinas Biopharma.